Mystic Asset Management Inc. Has $1.79 Million Stake in The Clorox Company (NYSE:CLX)

Mystic Asset Management Inc. lifted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 31.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 11,040 shares of the company's stock after acquiring an additional 2,657 shares during the quarter. Mystic Asset Management Inc.'s holdings in Clorox were worth $1,793,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Advisors Asset Management Inc. boosted its stake in shares of Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC boosted its stake in shares of Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock worth $10,341,000 after acquiring an additional 4,839 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock worth $117,932,000 after acquiring an additional 13,038 shares in the last quarter. Public Employees Retirement System of Ohio boosted its stake in shares of Clorox by 26.3% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company's stock worth $9,736,000 after acquiring an additional 12,428 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC bought a new stake in shares of Clorox during the 4th quarter worth about $204,000. Institutional investors own 78.53% of the company's stock.

Remove Ads

Clorox Stock Performance

Shares of CLX stock traded down $0.46 during mid-day trading on Friday, reaching $144.88. The stock had a trading volume of 1,553,392 shares, compared to its average volume of 1,211,967. The firm's 50 day simple moving average is $152.84 and its 200 day simple moving average is $159.78. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The firm has a market cap of $17.85 billion, a PE ratio of 39.58, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the firm posted $2.16 earnings per share. On average, analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.37%. Clorox's payout ratio is presently 133.33%.

Wall Street Analysts Forecast Growth

CLX has been the subject of several recent analyst reports. Wells Fargo & Company increased their target price on Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Barclays increased their target price on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Finally, StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.